OLD National Bancorp IN Purchases 264,877 Shares of Healthpeak Properties, Inc. $DOC

Key Points

• OLD National Bancorp IN increased its stake in Healthpeak Properties by 1,686.3% in Q4, buying 264,877 shares to hold 280,585 shares worth $4.512 million.
• Healthpeak beat expectations in the quarter with $0.47 EPS (vs. $0.45) and $719.4M revenue, and set FY2026 guidance of 1.700–1.740 EPS.
• The company announced a monthly dividend of $0.1017 (ex-dividend June 15), implying a 7.4% yield, while analysts maintain a consensus rating of "Hold" with a $19.04 target price.

OLD National Bancorp IN raised its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 1,686.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 280,585 shares of the real estate investment trust's stock after purchasing an additional 264,877 shares during the quarter. OLD National Bancorp IN's holdings in Healthpeak Properties were worth $4,512,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of DOC. Integrated Wealth Concepts LLC raised its position in Healthpeak Properties by 7.3% in the first quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust's stock valued at $366,000 after purchasing an additional 1,231 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Healthpeak Properties by 110.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust's stock valued at $2,463,000 after buying an additional 63,930 shares during the period. Woodline Partners LP increased its stake in shares of Healthpeak Properties by 41.3% in the first quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust's stock valued at $1,195,000 after buying an additional 17,279 shares during the period. Brown Advisory Inc. increased its stake in shares of Healthpeak Properties by 3.1% in the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust's stock valued at $819,000 after buying an additional 1,415 shares during the period. Finally, Qube Research & Technologies Ltd acquired a new stake in shares of Healthpeak Properties in the second quarter valued at about $3,117,000. 93.57% of the stock is currently owned by institutional investors.

Healthpeak Properties Trading Up 0.5%

NYSE DOC opened at $16.42 on Friday. The business has a 50 day simple moving average of $17.02 and a 200 day simple moving average of $17.26. Healthpeak Properties, Inc. has a one year low of $15.71 and a one year high of $19.68. The stock has a market capitalization of $11.41 billion, a P/E ratio of 164.17, a P/E/G ratio of 2.25 and a beta of 1.10. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.82 and a quick ratio of 2.82.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, topping the consensus estimate of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The business had revenue of $719.40 million during the quarter, compared to analysts' expectations of $685.14 million. During the same quarter last year, the firm posted $0.46 earnings per share. The firm's revenue was up 3.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Research analysts expect that Healthpeak Properties, Inc. will post 1.74 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be paid a $0.1017 dividend. This represents a c) dividend on an annualized basis and a yield of 7.4%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties's dividend payout ratio (DPR) is 1,220.00%.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on DOC shares. UBS Group started coverage on Healthpeak Properties in a research note on Monday. They issued a "neutral" rating and a $17.00 price target for the company. Cantor Fitzgerald set a $17.00 price target on Healthpeak Properties in a research note on Monday, January 5th. Robert W. Baird decreased their price target on Healthpeak Properties from $20.00 to $19.00 and set an "outperform" rating for the company in a research note on Monday, April 6th. Wells Fargo & Company reissued a "positive" rating on shares of Healthpeak Properties in a research note on Tuesday, February 3rd. Finally, The Goldman Sachs Group began coverage on Healthpeak Properties in a research note on Friday, January 9th. They set a "neutral" rating and a $17.00 target price for the company. Six investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $19.04.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.